A. A. Zgirovskaya, O. Novikova, Y. Lomako, M. A. Ananchikov, E. S. Tkalich, S. V. Dadashko, Viktor Ivanovich Gerasimenko
{"title":"DEVELOPMENT OF MEANS FOR THE SPECIFIC PREVENTION OF MYXOMATOSIS AND PASTEURELLOSIS IN RABBITS","authors":"A. A. Zgirovskaya, O. Novikova, Y. Lomako, M. A. Ananchikov, E. S. Tkalich, S. V. Dadashko, Viktor Ivanovich Gerasimenko","doi":"10.47612/2224-168x-2021-1-9-17","DOIUrl":null,"url":null,"abstract":"In the course of the work, an epizootic strain of the rabbit myxoma virus was isolated, and its adaptation to continuous cell cultures was carried out. When assessing the possibility of using an epizootic strain of myxoma of rab-bits for the manufacture of a vaccine, it was found that the isolated strain has low immunogenicity. \nFor the manufacture of a vaccine for the prevention of pasteurellosis, bordetelliosis and myxomatosis in rab-bits, the rabbit myxoma virus (strain KMIEV-V141), bacteria Pasteurella multocida (strain KMIEV-B166), and Bor-detella bronchiseptica (strain KMIEV-B212) were used; parameters of cultivation of strains of myxoma of rabbits, pas-teurella and bordetella were worked out, inactivants and adjuvants were selected, methods of inactivation of pasteurel-la and bordetella of rabbits were worked out. A vaccine sample for the prevention of pasteurellosis, bordetelliosis and myxomatosis in rabbits has been prepared.","PeriodicalId":232446,"journal":{"name":"Epizootology Immunobiology Pharmacology Sanitation","volume":"54 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epizootology Immunobiology Pharmacology Sanitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47612/2224-168x-2021-1-9-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In the course of the work, an epizootic strain of the rabbit myxoma virus was isolated, and its adaptation to continuous cell cultures was carried out. When assessing the possibility of using an epizootic strain of myxoma of rab-bits for the manufacture of a vaccine, it was found that the isolated strain has low immunogenicity.
For the manufacture of a vaccine for the prevention of pasteurellosis, bordetelliosis and myxomatosis in rab-bits, the rabbit myxoma virus (strain KMIEV-V141), bacteria Pasteurella multocida (strain KMIEV-B166), and Bor-detella bronchiseptica (strain KMIEV-B212) were used; parameters of cultivation of strains of myxoma of rabbits, pas-teurella and bordetella were worked out, inactivants and adjuvants were selected, methods of inactivation of pasteurel-la and bordetella of rabbits were worked out. A vaccine sample for the prevention of pasteurellosis, bordetelliosis and myxomatosis in rabbits has been prepared.